26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Diffuse large-B cell lymphomas (DLBCL) and follicular lymphomas (FL) are the most represented subtypes among mature B-cell neoplasms and originate from malignant B lymphocytes. Methylation represents one of the major epigenetic mechanisms of gene regulation. Silent information regulator 1 (SIRT1) is a class III lysine-deacetylase playing several functions and considered to be a context-dependent tumor promoter. We present the quantitative methylation, gene expression and tissue distribution of SIRT1 and some key mediators related to lymphoma pathogenesis in B lymphocytes purified from biopsies of follicular hyperplasias, FL and DLBCL. SIRT1 mRNA levels are higher in FL than follicular hyperplasias and DLBCL. B cell lymphoma 6 (BCL6) positively correlates with SIRT1. SIRT1 promoter shows a methylation decrease in the order: follicular hyperplasia - FL - DLBCL. Kruppel-like factor 4 (KLF4), Death-associated protein kinase 1 (DAPK1) and Spastic Paraplegia 20 (SPG20) methylation increase significantly in FL and DLBCL compared to follicular hyperplasias. Gene expression of DAPK1 and SPG20 inversely correlates with their degree of methylation. Our findings evidence a positive correlation between SIRT1 and BCL6 expression increase in FL. SIRT1 methylation decreases in FL and DLBCL accordingly and this parallels the increase of KLF4, DAPK1 and SPG20 methylation.

          Related collections

          Author and article information

          Journal
          Leuk. Res.
          Leukemia research
          Elsevier BV
          1873-5835
          0145-2126
          June 2017
          : 57
          Affiliations
          [1 ] Laboratory of Translational Research, Arcispedale S. Maria Nuova IRCCS, Viale Risorgimento 80, 42124 Reggio Emilia, Italy. Electronic address: raffaele.frazzi@asmn.re.it.
          [2 ] Laboratory of Translational Research, Arcispedale S. Maria Nuova IRCCS, Viale Risorgimento 80, 42124 Reggio Emilia, Italy. Electronic address: eleonora.zanetti@asmn.re.it.
          [3 ] Laboratory of Translational Research, Arcispedale S. Maria Nuova IRCCS, Viale Risorgimento 80, 42124 Reggio Emilia, Italy. Electronic address: mariaelena.pistoni@asmn.re.it.
          [4 ] Pathology Division, Arcispedale S. Maria Nuova IRCCS, Viale Risorgimento 80, 42124 Reggio Emilia, Italy. Electronic address: ione.tamagnini@asmn.re.it.
          [5 ] Pathology Division, Arcispedale S. Maria Nuova IRCCS, Viale Risorgimento 80, 42124 Reggio Emilia, Italy. Electronic address: riccardo.valli@asmn.re.it.
          [6 ] Scientific Direction, Arcispedale S. Maria Nuova IRCCS, Viale Umberto I, 42123 Reggio Emilia, Italy. Electronic address: luca.braglia@asmn.re.it.
          [7 ] Hematology Division, Arcispedale S. Maria Nuova IRCCS, Viale Risorgimento 80, 42124 Reggio Emilia, Italy. Electronic address: francesco.merli@asmn.re.it.
          Article
          S0145-2126(17)30068-1
          10.1016/j.leukres.2017.02.012
          28324774
          fbdfa16e-8ccb-43cf-a94f-0a091c4e30e7
          History

          Lymphoma,BCL6,B lymphocytes,SIRT1,Quantitative methylation
          Lymphoma, BCL6, B lymphocytes, SIRT1, Quantitative methylation

          Comments

          Comment on this article